Examkin

Question

Difficulty: Very hardOrdering Laboratory Tests

A 2222-year-old female college student is evaluated in the emergency department for severe, colicky abdominal pain, intractable nausea, and new-onset weakness in her bilateral upper extremities. She has a history of similar, albeit milder, abdominal pain episodes over the past 22 years. Her vital signs are notable for a heart rate of 122122/min and a blood pressure of 168/105168/105 mm Hg. Physical examination demonstrates generalized abdominal tenderness without rigidity or rebound. Initial laboratory workup reveals a serum sodium of 126126 mEq/L, with a normal lipase level, liver transaminases, and complete blood count. An abdominal ultrasound is unremarkable. Upon returning from the radiology suite, the nurse notes that the patient's urine in the bedside collection container has developed a deep red-purple hue after being exposed to ambient light. Arrange the following laboratory investigations in the most evidence-based sequential order for the diagnostic workup of this patient's suspected metabolic disorder.

  1. 1Measurement of spot urine porphobilinogen (PBG) and delta-aminolevulinic acid (ALA) normalized to urine creatinine
  2. 2Fractionation of plasma and fecal porphyrins
  3. 3Erythrocyte hydroxymethylbilane synthase (HMBS) enzyme activity assay
  4. 4Targeted molecular genetic sequencing of the HMBS gene

Answer

The correct sequence is to first obtain a spot urine test for PBG and ALA, followed by plasma and fecal porphyrin fractionation, then measure erythrocyte HMBS enzyme activity, and finally perform targeted molecular genetic sequencing.
The evidence-based sequence for diagnosing acute intermittent porphyria begins with a sensitive rapid screening test (spot urine PBG and ALA) to confirm an acute attack. Because elevated PBG is shared by multiple acute porphyrias, the next step is biochemical differentiation using plasma and fecal porphyrins. After the biochemical phenotype suggests a specific porphyria (AIP), the corresponding functional enzyme assay (erythrocyte HMBS) is checked. The final step is molecular genetic testing to pinpoint the exact mutation, primarily used to facilitate screening of family members.

Step-by-Step Solution

1
Identify the clinical presentation of an acute hepatic porphyria attack.
The triad of unexplained acute neurovisceral pain, dysautonomia (tachycardia, hypertension), hyponatremia, and light-sensitive dark urine points strongly to an acute porphyria.
Recognizing the toxidrome prevents unnecessary surgical exploration and dictates the initiation of a highly specialized biochemical laboratory workup.
2
Order a rapid initial biochemical screening test.
Spot urine PBG and ALA normalized to creatinine are ordered as the first-line test.
These porphyrin precursors are profoundly elevated during an acute attack. A spot test provides the most sensitive, rapid diagnostic confirmation needed to justify administering definitive therapy (e.g., intravenous hemin).
3
Differentiate the specific subtype of acute porphyria.
Plasma and fecal porphyrin fractionation is ordered as the second step.
Elevated PBG and ALA occur in Acute Intermittent Porphyria (AIP), Variegate Porphyria (VP), and Hereditary Coproporphyria (HCP). Fecal porphyrins effectively separate AIP (normal/low levels) from VP and HCP (highly elevated levels).
4
Confirm the functional enzymatic deficiency.
Erythrocyte HMBS (previously PBG deaminase) enzyme assay is performed.
Once the biochemical pattern suggests AIP, demonstrating the specific enzymatic block in the heme synthesis pathway confirms the functional defect.
5
Establish the definitive molecular diagnosis.
Targeted HMBS gene sequencing is ordered.
This definitively confirms the condition at the DNA level and is essential for enabling genetic counseling and cascade testing for asymptomatic relatives.

Key Concept

The diagnostic algorithm for acute hepatic porphyrias follows a strict sequence: initial rapid biochemical confirmation with spot urine porphobilinogen (PBG), followed by subtype differentiation with fecal/plasma porphyrins, enzyme activity confirmation, and finally, molecular genetic testing.
Estimated Time:2m 30s
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic